Showing results (481-490 of 516) with videos related to

Sort By:
Pageof 52
Nature Communications|March 10, 2016
Genome-wide association analysis identifies novel loci for chronotype in 100,420 individuals from the UK BiobankJacqueline M Lane, Irma Vlasac, Simon G Anderson, et al.
Journal of the American College of Radiology : JACR|May 19, 2024
Building Radiology Equity: Themes from the 2023 RAD-AID Conference on International Radiology and Global HealthAnne-Marie Lugossy, Kevin Anton, Farouk Dako, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 28, 2021
Late Conditions Diagnosed 1-4 Months Following an Initial Coronavirus Disease 2019 (COVID-19) Encounter: A Matched-Cohort Study Using Inpatient and Outpatient Administrative Data-United States, 1 March-30 June 2020Jennifer R Chevinsky, Guoyu Tao, Amy M Lavery, et al.
NPJ Digital Medicine|November 1, 2019
How the weather affects the pain of citizen scientists using a smartphone appWilliam G Dixon, Anna L Beukenhorst, Belay B Yimer, et al.
Annals of the Rheumatic Diseases|March 23, 2019
2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritisLisa Ehlers, Johan Askling, Hans Wj Bijlsma, et al.
Annals of the Rheumatic Diseases|August 21, 2017
Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative projectLouise K Mercer, Anne C Regierer, Xavier Mariette, et al.
Research Square|January 10, 2024
Alliance for Clinical Trials in Oncology (Alliance) trial A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur)Kathryn E Hitchcock, Eric D Miller, Qian Shi, et al.
BMC Cancer|February 13, 2024
Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur)Kathryn E Hitchcock, Eric D Miller, Qian Shi, et al.
Journal of the National Cancer Institute|September 10, 2021
Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer TrialsJun Yin, Mohamed E Salem, Jesse G Dixon, et al.
MMWR. Morbidity and Mortality Weekly Report|July 8, 2021
Outcomes Among Patients Referred to Outpatient Rehabilitation Clinics After COVID-19 diagnosis - United States, January 2020-March 2021Jessica S Rogers-Brown, Valentine Wanga, Catherine Okoro, et al.
Pageof 52